Your session is about to expire
← Back to Search
Procedure
HIFU for Prostate Cancer (STAR Trial)
N/A
Waitlist Available
Research Sponsored by SonaCare Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a treatment that uses focused sound waves to destroy prostate cancer cells in men whose cancer has returned after radiation therapy. The sound waves heat and kill the cancer cells without surgery. This is an emerging minimally invasive treatment option for prostate cancer.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: HIFUExperimental Treatment1 Intervention
High Intensity Focused Ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High Intensity Focused Ultrasound
2006
Completed Phase 2
~90
Find a Location
Who is running the clinical trial?
SonaCare MedicalLead Sponsor
6 Previous Clinical Trials
560 Total Patients Enrolled
3 Trials studying Prostate Cancer
486 Patients Enrolled for Prostate Cancer
Mark Carol, MDStudy DirectorSonaCare Medical, LLC
Share this study with friends
Copy Link
Messenger